trending Market Intelligence /marketintelligence/en/news-insights/trending/OLXW8YolHaBhsk1zem_6Hg2 content esgSubNav
In This List

Roche's cobas Zika virus test gets US FDA approval

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Roche's cobas Zika virus test gets US FDA approval

Roche Holding AG secured the U.S. Food and Drug Administration's approval for the cobas Zika test.

Cobas is the first commercially available test for the detection of the Zika virus RNA in samples of human plasma intended for use in screening blood donations.

Roche deployed the cobas Zika test in April 2016 under the FDA's investigational new drug application protocol to screen blood donations collected in Puerto Rico.